A pioneering surgical blood salvage technology developed at
the University of Strathclyde, Glasgow, is set to transform the way major
surgery is carried out by reducing blood loss in patients.
HemoSep is set to revolutionise the health care sector after
gaining the CE mark and receiving Canadian national approval, following highly
successful clinical trials in the world leading University of Kirikkale
University Hospital in Ankara, Turkey.